Author: Lyalkin S.A.

April 2, 2020

Efficacy of the second line chemotherapy in patients with metastatic triple negative breast cancer. Results of randomized study
Lyalkin S.A.
｜
Verevkina N.O.
｜
Syvak L.A.

«Morion» publishing house

Editorial office and publisher: 02072, Kyiv, ave. Bazhana 10A

+380 (44) 585-97-10

Limitation of liability

Professional scientific and practical edition for health care specialists